engineered to avoid proteolytic degradation. This reProteolytic degradation of recombinant proteins view focuses mainly on these ''upstream design'' straterepresents a major problem related to production of gies, which can be either highly product specific or gene products in heterologous hosts. Recombinant rather general in their nature.
A major consideration when setting up a production zation of fermentation conditions or downstream pro-scheme for a recombinant protein is whether the prodcessing schemes. In this review, various genetic ap-uct should be expressed intracellularly or if a secretion proaches to improve the stability of recombinant pro-system could be used to direct the protein out of the teins will be discussed, including (i) choice of host cell host cell. There exists no generally applicable strategy strain, (ii) product localization, (iii) use of gene fusion that guarantees efficient expression. Instead, the inpartners, and (iv) product engineering. In addition, herent properties of the target protein decide which the solubility of the gene product can be influenced production route will be most successful, both in terms by factors such as growth temperature, promoter of expression level and in terms of product stability. strength, fusion partners, and site-directed changes. The different production routes, important factors to Altogether, a battery of approaches can be used to ob-consider, problems that can be encountered, and how tain stable gene products. ᭧ 1996 Academic Press, Inc. these problems might be circumvented are presented in Fig. 1 .
Fusion to a leader (signal) peptide can for certain gene products be used to direct the proteins out of the When producing mammalian proteins in a bacterial host such as Escherichia coli, proteolytic degradation host cells (5,6). For E. coli, several systems have been described for the secretion of the gene product to the of the gene product might lead to significantly reduced yields and difficulties in setting up cost-effective pro-culture medium (7-12) or the periplasm (13) (14) (15) (16) .
There are a number of advantages connected with the duction schemes. The degradation might occur during the cell harvest and recovery procedures but is nor-secretion strategy, including enhanced disulfide bond formation in the oxidative environment outside the cymally initiated during the cultivation. A number of different strategies to decrease the proteolytic degrada-toplasm, which might improve folding (9, 15, 17) and very much simplified recovery of the recombinant protion of the product by modification of the downstream processing schemes or by optimization of fermentation tein since a large degree of the purification has been achieved through the secretion (17, 18) . However, there conditions have earlier been presented (1-4). However, these strategies have in general rather limited influ-is no guarantee that a certain protein can be secreted even if an expression system with secretion signals is ence on the quality of the product. In contrast, recombinant DNA techniques offer more directed strategies to chosen for the production. Proteins with a strong tendency to precipitate intracellularly and proteins conminimize proteolysis. Both the host cell used for the production and the product can by genetic means be taining hydrophobic transmembrane regions have been
FIG. 1.
The mind map for recombinant E. coli production. Factors like product solubility and stability together with possibilities for secretion decide which route will be the most suitable for production of the target protein. As can be seen at the bottom, the number of essential unit operations will depend upon the selected production route.
demonstrated to be difficult to secrete (19, 20) . Intracel-sented in Table 1 . A selection of examples involving strain and product engineering will be discussed below. lular expression of nonsecretable proteins might be an attractive alternative due to recent advances for in vitro renaturation of recombinant proteins from intra-Choice of Host Cell cellular precipitates (21) .
A strategy to enhance the in vivo stability of a labile If a secretion strategy proves to be successful, mean-recombinant protein is to use an E. coli host that lacks ing that the product can be secreted out to the culture a protease or proteases, or other regulatory proteins, medium and at the same time no proteolytic degrada-involved in the degradation (Table 1) . There are several tion occurs, there exists no real obstacle to setting up examples of this method in the literature (23-29,43-a cost-efficient production scheme for the product. After 45). By using a lon strain, deficient in the La protease a cell separation step, the gene product has to be sepa-which is a cytoplasmic protease that seems to be largely rated from only a few other proteins and the culture responsible for degradation of proteins with nonnative medium constituents. If the product is partly degraded, structures (46) , stabilization of the recombinant prodifferent strategies exist to improve product stability tein can be obtained (45) . Strains that do not produce (Fig. 1) . If the product is not possible to secrete, an the alternate s-factor, s 32 , which controls the transcripintracellular production scheme needs to be investi-tion of heat shock genes, have been demonstrated to gated. If a majority of the product is found in a soluble have a decreased capacity to degrade unstable or abform and not degraded by host proteases, a relatively normal proteins, in addition to being defective in the straight-forward recovery scheme could be envisioned, heat shock response (28,45). It has also been shown obviously initiated by a cell disruption step. If the solu-that several chaperone proteins are involved in the proble fraction of the intracellularly expressed protein is tein degradation process, and the use of dnaK, dnaJ, found to be degraded, again different strategies to sta-grpE, or groEL mutant strains have been discussed as bilize the product can be evaluated (Fig. 1) . If an intra-potential alternatives for expression of foreign, unstacellularly expressed gene product has a strong ten-ble proteins in E. coli (1, 45, 47) . However, results from dency to precipitate, proteolytic degradation is gener-such studies do not suggest any general solutions, since ally rather limited but the recovery scheme needs to although a dnaK deletion can have a stabilizing effect include renaturation of the recombinant protein to for one product (29) , overexpression of the same chaperyield a correctly folded product (21) .
one can increase the in vivo half life 10-fold for another
STABILIZATION STRATEGIES
product (31) . Determinations of how certain chaperones influence the stability of a given protein will have An overview of some of the investigated strategies that have been employed to avoid proteolysis is pre-to be made empirically. Nevertheless, overproduction of the chaperones GroEL/ES has shown to increase the (26) . Similarly, an IGF-II fusion designed for secretion was degraded at basic amino acid sequences when proin vivo half life for certain products (30).
Since secretion systems are attractive for large-duced in E. coli (40). An ompT 0 strain was also tried as production host for different IGF-II fusions, leading scale production of recombinant proteins, significant efforts have been devoted to the development of to significantly more stable products (49, 50) .
Along this line of research, E. coli strains with double strains lacking proteases in the E. coli cell envelope (Table 1) . Strauch and Beckwith (22) reported the use and triple mutants of envelope proteases (27) have been created to be suitable production strains for secreted of a mutant E. coli strain lacking the DegP proteolytic activity in the periplasm, which gave a complete sta-products. Unfortunately, by creating hosts deficient in multiple proteases, the viability and thus growth propbilization of a fusion protein comprising alkaline phosphatase and the inner membrane protein Tsr. erties of the strain is impaired. Recently, a set of 20 different mutant strains was presented (44) in an atThere are now several reports showing that other recombinant proteins expressed in E. coli and secreted tempt to generate E. coli host strains which exhibit the optimal combinations of growth properties and protein to the periplasm can also be stabilized when produced in a degP 0 strain (23 -25). stability. If one has access to a set of such strains when setting up a production scheme for a recombinant prod-A fusion between staphylococcal protein A (SpA) and E. coli b-galactosidase was demonstrated to be proteo-uct it is of course possible to test a number of strains in parallel to select a suitable host strain. lytically processed when produced intracellularly in E. coli (26) . A cleavage occurred in the linker region between the two functional units and the cleavage site, Secretion of the Gene Product identified by N-terminal peptide sequencing, was found to be at two basic amino acids, Arg-Lys. The outer Gene fusions are widely used tools in biotechnology. By means of molecular biology, it has become possible membrane protein T (OmpT), which recognizes and cleaves at dibasic amino acid sequences (48) , was sug-to give proteins additional properties through gene fusions. A type of gene fusion which has been used extengested to be responsible for this degradation since the degradation occurred during disintegration of the cells sively is the fusion of a signal sequence to the gene encoding the protein of interest, in order to localize and the proteolytic activity was mapped to the outer membrane. When using an ompT 0 strain for the pro-the recombinant gene product to the periplasm and/or growth medium, with the primary purpose of simpliduction, complete stabilization was indeed obtained fying product recovery. As mentioned above, there exist in inclusion body formation (56) . In addition, expression from strong promoters such as the T7 promoter for E. coli a number of secretion systems that have proved beneficial, and the most attractive ones are of (57), leading to very high expression levels, seems to increase the tendency for intracellular aggregation of course those that secrete the protein to the culture medium (5,18).
the produced recombinant protein (21, 58) . Production by the inclusion body strategy has the main advantages More than 20 proteases have to date been identified in E. coli (Fig. 2) , of which approximately 50% are local-that the recombinant product normally is protected from proteolysis (21, 59 ) and that it can be produced in ized in the cytoplasm. Extensive reviews have recently been published (51) (52) (53) . By secretion to the periplasm large quantities. Levels of up to 50% of total cell protein content have been reported (21, 26) . If an intracellularly or to the culture medium, stabilization of recombinant proteins can thus potentially be achieved. Talmadge produced recombinant product exists as partly soluble and partly precipitated material, and the soluble mateand Gilbert (33) demonstrated that the in vivo half life of rat proinsulin increased 10 times when secreted to rial is significantly degraded, it is obviously of interest to increase the amount of precipitated material. This the periplasm, as compared to when located in the cytoplasm. However, this is not a general phenomenon and could be achieved by increasing the expression level by the use of strong promoter systems (e.g., the T7 system) the direction of a recombinant protein to the secretion apparatus could in some cases lead to degradation and high copy number plasmids. By altering growth conditions that lead to increased gene expression, such (43,54). Obviously, the inherent properties of the recombinant protein determine whether the protein is as elevated growth temperature or gene induction level (60) , an increase in inclusion body formation can also be stabilized by secretion or not. For example, stabilization due to translocation has been reported for frag-obtained. Intracellular production and recovery from inclusion bodies have become more attractive due to ments of the F glycoprotein from human respiratory syncytial virus (19) , human epidermal growth factor recent advances for in vitro renaturation of recombinant proteins from intracellular precipitates (21) and (34), and human cysteine proteinase inhibitor (55) .
gene fusion technology which has also contributed to However, many recombinant proteins cannot be transstrategies for recovery of proteins with low solubility located through the E. coli inner membrane. They are (19) . either secretion incompetent or form inclusion bodies
In contrast, if no problems with proteolysis exist in the cytoplasm. When this is the case, an intracellular during intracellular production, it might be desired to production strategy has to be used.
obtain the recombinant protein in a soluble form (Fig.  1) . Increased solubility might be achieved by lowering Improved Recovery via Inclusion Body Formation the growth temperature (2,3,60,61), by fusion to soluThe mechanisms for inclusion body formation are not ble fusion partner like the ZZ-tail from protein A fully elucidated but fusions to certain proteins, such as (61,62) or thioredoxin (63) or by hydrophobicity engineering (41,42). TrpE and to a lesser extent b-galactosidase, may result
Gene Fusions for Product Stabilization
or other functional properties, it might be possible to either delete or substitute amino acids in the recogniFusions to homologous or heterologous genes have tion sequence to obtain a stable gene product. A fusion proved to provide stabilization of recombinant proteins.
protein SpA-b-galactosidase was shown to be proteoUnfused proinsulin showed a very short in vivo half lytically digested by the OmpT-protease at a basic dilife in the E. coli cytoplasm (33). In contrast, when the peptide sequence in the linker region between the two proinsulin gene was fused to a single copy of itself, a functional units (26) . A modified SpA-b-galactosidase significant stabilization was achieved (36) . Proinsulin fusion lacking the basic amino acids retained IgG-bindhas also been produced in a fairly stable form as a ing and b-galactosidase activities. Stability studies on fusion to the IgG-binding ZZ-tail, although several degthe modified fusion protein revealed that it was comradation products were obtained together with the full pletely stable when incubated with E. coli cell disintelength fusion protein after affinity chromatography grate, as compared to the original fusion that was al-(37). Bowie and Sauer (38) demonstrated that a mutant most completely degraded after 4 h incubation under form of the phage repressor protein P22 Arc, expressed the same conditions (26) . Similar strategies have also intracellularly, could be stabilized in vivo by a 25 amino been employed in attempts to increase in vitro protein acid C-terminal extension. This peptide also stabilized stability of therapeutical products such as insulin. Sina labile mutant form of the l-repressor when fused at gle amino acid substitutions have resulted in signifithe C-terminal. A eukaryotic protein, ubiquitin, has cantly improved product stability (61,67). been used as a fusion partner for E. coli production As discussed earlier, heterologous protein expresof recombinant proteins. In contrast to its function in sion in recombinant hosts like E. coli often leads to eukaryotic systems where it targets certain proteins to accumulation of the protein in an improperly folded, degradation, ubiquitin stabilizes the recombinant prononactive form as inclusion bodies (21,68). This pheteins in E. coli (39, 65) .
nomenon can sometimes be advantageous due to inFusion strategies can increase the stability of recreased protein stability (58, 59) . However, refolding combinant proteins produced in E. coli compared to schemes to obtain correctly folded proteins usually inthe native protein, but nevertheless, heterogeneous volve the use of strong denaturants like guanidine mixtures of product molecules are often obtained hydrochloride and urea to resolubilize the inclusion after purification. In an attempt to avoid this problem bodies, which can lead to unwanted chemical modifia dual affinity fusion strategy was developed to enable cations of the recombinant protein. Guanidine hydrospecific recovery of only full length products (40). This chloride is rather expensive and highly corrosive, strategy, where proteins of interest were fused bewhich makes it less suitable for industrial use. The tween two affinity tags, the IgG-binding ZZ and the refolding is usually performed at low protein concenalbumin binding ABP, resulted in a considerable statrations to avoid aggregation, generating large workbilization of several mammalian proteins (IGF-II, ing volumes. Taken together, these properties can proinsulin, a thioredoxin homologous domain of rat lead to high costs and extended processing schemes protein disulfide isomerase and a part (Va) of a hufor the production and the recovery of recombinant man T-cell receptor) which were all unstable when proteins. Therefore, a major challenge in recombinant produced as single fusions (37,40). In addition, conexpression is to design schemes for soluble production. secutive affinity purifications on IgG-Sepharose (usFour major routes to increase the solubility of recoming the ZZ fusion partner) and human serum albumin binant proteins have so far been investigated. LowSepharose (using the ABP fusion partner) yielded ering the growth temperature often yields a larger highly purified full length fusion proteins (37,40).
amount of soluble protein (60, 61, 69) . It has also been Plasmid systems for E. coli expression of dual affinity suggested that coexpression of chaperones should lead fusions have been designed for both secreted and into a larger fraction of soluble recombinant protein tracellular production (19, 40) . A related dual affinity (70) . This hypothesis is supported by some reports system was developed for purification of staphylococabout coexpression of GroEL and GroES for produccal protein A deletion mutants (66). The N-and Ction of active proteins in E. coli (30, 71) . A third alterterminal affinity handles were in this case the albunative strategy is to fuse the protein of interest to a min-binding ABP and a Zn 2/ -binding histidine tag, soluble fusion partner, leading to an increased solubilrespectively. Also this strategy exhibited a stabilizing ity. Samuelsson and co-workers (62) have described effect on the labile target protein, in addition to prothe use of the SpA derivative ZZ to increase the soluviding means for specific purification of full length bility of human IGF-I. When IGF-I was fused to ZZ, proteins (66).
the in vitro solubility was increased at least 100 times Protein Engineering to Avoid Proteolysis as compared to unfused IGF-I. The ZZ-tail has also been shown to be a useful tool in in vitro refolding of When a proteolytically sensitive site is located in a region of a protein not important for activity, folding, IGF-I, probably acting in a ''chaperone-like'' manner, preventing aggregation of unfolded fusion proteins production is utilized, the gene product could be recovered either from inclusion bodies or from the fraction thus giving significantly reduced working volumes and more cost-effective downstream processing (63) . of soluble proteins, depending on inherent properties of the gene product and the expression rate. If a majorLaVallie and co-workers (64) have used the highly soluble protein thioredoxin to produce large amounts of ity of the protein is found as inclusion bodies, the target protein is most probably protected from proteolytic degsoluble recombinant proteins in the E. coli cytosol. A fourth strategy is to perform site-directed mutagene-radation, but a renaturation scheme has to be set up for the recovery of correctly folded product. If a soluble sis of specific residues to alter stability and solubility properties of recombinant proteins. Few systematic protein is degraded in the cytoplasm, different strategies employing gene fusions could be investigated to studies of this strategy are reported although such small specific modifications have been shown to alter achieve stabilization. A secretion strategy could be evaluated by fusing the target gene to signals resulting properties like solubility and stability of the recombinant protein (26, 41, 60, 61, 68, 72) . Rinas and co-work-in secretion of the gene fusion product. Alternatively, single or dual fusions could be tested for product stabiers (41) showed that different single cysteine substitution in human basic fibroblast growth factor (bFGF) lization. Such fusion tags could be chosen also to enable affinity purification which would be beneficial for efficould cause either an increase or a decrease in solubility. Luck and co-workers (73) demonstrated that by cient product recovery. However, depending on the final use of the product, the fusion tails might have to replacing cysteines with serines in bovine prolactin, a significant increase in the protein solubility was be removed by chemical or enzymatic cleavage of the purified gene product (74-76). If proteolytic degradaachieved. Different strategies to alter protein solubility were recently reviewed (6).
tion at a specific site is predominant and the site can be defined, site-directed mutagenesis could be employed Recently, site-directed mutagenesis was employed to engineer the hydrophobic properties of a 101 amino to create a slightly modified product that should be protected from proteolysis. Gene fusion technology or acid fragment from the human respiratory syncytial virus major glycoprotein (42) . Hydrophobic engineering site-directed mutagenesis could also be utilized to alter the hydrophobic properties of the target protein, since of four clustered phenylalanine residues, yielding mutant variants with the four phenylalanine residues ei-in certain cases increased solubility is accompanied with improved proteolytic stabilization (41, 42) . To conther substituted (for serine residues) or deleted, increased the fraction of soluble protein in vivo from 27 clude, the different strategies for stabilization presented in this review are valuable tools for evaluation to 75%. Interestingly, this effect was accompanied by a remarkable increase in product stability. Protein en-and development of possible production strategies, but the method of choice is obviously depending on the ingineering of hydrophobic residues obviously could influence protein structure but in the reported example, herent properties and final use of the target product. circular dichroism analysis and antigenicity pattern suggested a retained structure (42) . Similarly, the solu-REFERENCES bilizing effect observed for a Ser88Cys mutant of bFGF erties of many of these strains (27,44). If intracellular
